Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - Formulators
  4. /Amrutanjan Health Care Ltd
MomentumDeep Value

Amrutanjan Health Care Ltd: Stock Analysis & Fundamentals

Updated this week

Amrutanjan Health Care Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 25.5. ROE: 16.5%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

🏦Virtually debt-free company
🏛️DII accumulation — stake up 2.3%

Key Numbers

Current Price
₹509
Dividend Yield
0.90%
Market Cap
1.5K Cr
Valuation
N/A

Other Top Pharma - Formulators Stocks Beating Nifty 500

Sun Pharmaceutical Industries Ltd
Strong • 4w streak
+15.9%
Torrent Pharmaceuticals Ltd
Average • 12w streak
+23.4%
Dr Reddys Laboratories Ltd
Average • 5w streak
+12.6%
Lupin Ltd
Average • 12w streak
+22.1%
Zydus Lifesciences Ltd
Weak
+10.0%
← Back to Pharma - FormulatorsDashboard

Frequently Asked Questions: Amrutanjan Health Care Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Amrutanjan Health Care Ltd's latest quarterly results?

Amrutanjan Health Care Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: 0.0%
  • Revenue Growth YoY: +14.6%
  • Operating Margin: 18.0%

What is Amrutanjan Health Care Ltd's current PE ratio?

Amrutanjan Health Care Ltd's current PE ratio is 25.5x.

  • Current PE: 25.5x
  • Market Cap: 1.5K Cr
  • Dividend Yield: 0.90%

What is Amrutanjan Health Care Ltd's price-to-book ratio?

Amrutanjan Health Care Ltd's price-to-book ratio is 4.3x.

  • Price-to-Book (P/B): 4.3x
  • Book Value per Share: ₹118
  • Current Price: ₹509

Is Amrutanjan Health Care Ltd a fundamentally strong company?

Amrutanjan Health Care Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 22.0%

Is Amrutanjan Health Care Ltd debt free?

Amrutanjan Health Care Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹2 Cr

What is Amrutanjan Health Care Ltd's return on equity (ROE) and ROCE?

Amrutanjan Health Care Ltd's return ratios over recent years

  • FY2023: ROCE 19.0%
  • FY2024: ROCE 21.0%
  • FY2025: ROCE 22.0%

Is Amrutanjan Health Care Ltd's cash flow positive?

Amrutanjan Health Care Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹51 Cr
  • Free Cash Flow (FCF): ₹20 Cr
  • CFO/PAT Ratio: 100% (strong cash conversion)

What is Amrutanjan Health Care Ltd's dividend yield?

Amrutanjan Health Care Ltd's current dividend yield is 0.90%.

  • Dividend Yield: 0.90%
  • Current Price: ₹509

Who holds Amrutanjan Health Care Ltd shares — promoters, FII, DII?

Amrutanjan Health Care Ltd's shareholding pattern (Dec 2025)

  • Promoters: 46.5%
  • FII (Foreign): 2.3%
  • DII (Domestic): 13.0%
  • Public: 38.2%

Is promoter holding increasing or decreasing in Amrutanjan Health Care Ltd?

Amrutanjan Health Care Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 46.5% (Dec 2025)
  • Previous Quarter: 46.5% (Sep 2025)
  • Change: 0.00% (stable)

Is Amrutanjan Health Care Ltd a new momentum entry or an established outperformer?

Amrutanjan Health Care Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Amrutanjan Health Care Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Amrutanjan Health Care Ltd may be worth studying

  • Cash flow is positive — CFO ₹51 Cr

What is the investment thesis for Amrutanjan Health Care Ltd?

Amrutanjan Health Care Ltd investment thesis summary:

What is the future outlook for Amrutanjan Health Care Ltd?

Amrutanjan Health Care Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.